IPO Profile: Aldeyra Therapeutics Inc

Domain Associates, Johnson & Johnson and others invested about $19 million and realized a total return of 1.6x at the time of IPO

ByLarry Oberfeld

13 June 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.